Why most curcumin falls short for inflammation, joint comfort and recovery

Curcumin, the active ingredient in Turmeric, is notoriously difficult to absorb. That's not marketing. It's chemistry.

Curcumin is fat-soluble, so it barely dissolves in water. And guess what? Your digestive system is mostly water. Whatever does get through is converted and cleared quickly by your liver and gut lining. Most of what you swallow leaves your body without ever reaching your bloodstream. [6]

So the milligrams on the front of the bottle tell you what you swallowed. They tell you very little about what was actually absorbed by your body.

This is why every serious curcumin brand is really selling a delivery format, whether they say so or not. The formats aren't equal, and neither are the numbers used to sell them.

1. More bioavailable than what?

Every multiplier needs something to be measured against, and brands choose different starting points. Some compare against raw turmeric powder. Some against a standard extract. Some against purified curcumin.

Those are three different baselines. A bigger multiplier can simply mean a weaker thing to compare against.

2. Total absorption, or peak level?

Some figures measure the total amount reaching your blood across 24 hours. Others measure the single highest point it touches. The same product can produce numbers several times apart depending on which one is chosen, and both can be honest.

3. At what dose?

The black pepper figure behind much of what's on the shelf comes from a 1998 study where volunteers took 2 grams of curcumin in a single dose. [1] Most curcumin capsules on the shelf contain 500mg to 1,000mg per serving — so that 1998 study used two to four times what a typical capsule actually delivers.

Dose matters even within one technology. Published trials on micellar curcumin have reported 185-fold, 88-fold, and 57-fold increases over native curcumin, from the same research group, at different doses and in different study designs. [2] [3] [4] All three are accurate. None of them is comparable to the others.

4. What exactly was counted?

Once absorbed, most curcumin circulates in a converted form. Some labs measure everything present. Others count only the small unconverted fraction. Two different endpoints, two very different-looking results.

The short version: two multipliers are only comparable if they came from the same trial, the same lab and the same people. Anywhere else, a multiplier is a claim rather than a measurement.

Most absorption claims come from a brand testing its own product against plain curcumin. That tells you something, but it never tells you how the formats compare with each other.

Two trials have done that properly.

Worth being precise about what that result shows. The micellar product actually delivered fewer curcuminoids than the colloidal suspension it was measured against, 63mg versus 89mg, and still produced more in the blood, both in total and per milligram ingested. On the trial's main measure it came out highest of all five formats tested. That trial was designed and funded by a company selling a competing format, which makes the result harder to dismiss, not easier. [5]

We didn't pick a technology and build a story around it. We started with how your body already absorbs fat, and built the formula to match.

KURK was developed over six years in our purpose-built lab by a team that includes a medical doctor who co-founded the company. We make it ourselves, in-house, independently batch tested — no heavy metals, fillers or solvents. It isn't bought from a catalogue and relabelled, which is how most of this category operates.

It's 100% plant-based, with no fillers or preservatives, and independently lab-tested for purity and heavy metals.

You take 1 to 2ml a day, in coffee, water or food. That's the whole routine.

Here's something most brands in this category won't tell you.

The absorption research above was carried out on micellar formulations, not on KURK specifically. It supports the format. It isn't a measurement of our bottle. Plenty of brands quote figures like these as though they were, and we're not going to.

What we're doing about it. A two-year Knowledge Transfer Partnership with Swansea University Medical School, backed by Innovate UK, now places a researcher inside our laboratory full-time. It follows an earlier Innovate UK project with the same team. The roadmap runs from cell models to plasma and blood, and then to formal human trials.

Whatever those trials find will be published, whichever way they go. In a category built on unreplicated numbers from the 1990s, we'd rather tell you where the evidence actually stands.

Four questions. They'll tell you more than the front of any bottle.

That's the standard we'd like this category held to, ourselves included.